Colgate Looks To Aging Gums, Whitening Launches For Growth In 2012
This article was originally published in The Rose Sheet
Colgate-Palmolive plans oral-care launches in 2012 aimed at aging consumers seeking gum protection as well as consumers looking for “a shinier, sparkling smile.” Firm reports fiscal 2011 sales of $16.7 billion, up 7.5% from the year prior.
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.